Bisphosphonate therapy ‘can have an impact on dental impact surgery’

Women who have received dental implant surgery may see a negative impact if they are also receiving bisphosphonate therapy for osteoporosis.

This is according to new research from Kanagawa Dental University Hospital and the Tokyo Medical and Dental University, who recently performed a study focused on the use of bisphosphonate therapy and its effect on the quality of the mandible.

Examining 25 female patients over the age of 60 who had been diagnosed with osteoporosis and had also undergone dental implant surgery, it was found that a proportion of those receiving bisphosphonates saw a number of implant failures, which did not occur among those who did not receive this medication.

Overall, the researchers believe that bisphosphonate use may be correlated with increased bone mineral density and cortical bone thickness, potentially increasing the chances of early implant failure.

The researchers concluded: "These results indicate that bisphosphonates affect the quality and quantity of the cortical bone in the partially edentulous posterior mandible of patients with osteoporosis, which should be considered prior to treatment with dental implants in patients taking bisphosphonates."

With over 20 years of experience within the dental market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current dental roles we have available, you can search for the latest job roles, register your details, or contact the team today.